Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Guilherme Fleury Perini
Hospital Israelita Albert Einstein
Brazil
Contact
Hospital Israelita Albert Einstein
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
197
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
KEYNOTE-204: A Multicentre, Randomised, Open-Label, Phase 3 Study of Pembrolizumab
versus
Brentuximab Vedotin in Relapsed or Refractory Classical Hodgkin Lymphoma
Number of pages: 47
Posted: 12 Oct 2020
John Kuruvilla
,
Radhakrishnan Ramchandren
,
Armando Santoro
,
Ewa Paszkiewicz-Kozik
,
Robin Gasiorowski
,
Nathalie A. Johnson
,
Laura Maria Fogliatto
,
Iara Gonclaves
,
Jose S. R. de Oliveira
,
Valeria Buccheri
, Guilherme Fleury Perini,
Neta Goldschmidt
,
Iryna Kriachok
,
Michael Dickinson
,
Mieczyslaw Komarnicki
,
Andrew McDonald
,
Muhit Ozcan
,
Naohiro Sekiguchi
,
Ying Zhu
,
Akash Nahar
,
Patricia Marinello
,
Pier Luigi Zinzani
and
The KEYNOTE-204 Investigators
University of Toronto - Princess Margaret Cancer Centre, University of Tennessee, Knoxville, Humanitas University - Department of Biomedical Sciences, Maria Sklodowska-Curie National Institute of Oncology, The University of Sydney - Concord Hospital, Jewish General Hospital, Montreal, Hospital de Clinicas de Porto Alegre, Fundação Pio XII - Hospital de Câncer de Barretos, Casa de Saude Santa Marcelina, University of São Paulo (USP) - Hospital das Clínicas, Hospital Israelita Albert Einstein, Hebrew University of Jerusalem - Hadassah Medical Center, National Cancer Institute, Kiev, Peter MacCallum Cancer Centre, Szpital Kliniczny im. Przemienienia, Pretoria East Hospital, Ankara Üniversitesi Tip Fakültesi, National Hospital Organization Disaster Medical Center, Merck & Co., Inc., Merck & Co., Inc., Merck & Co., Inc., Universitaria di Bologna - Azienda Ospedaliero and Independent
Downloads
197
(393,598)
View PDF
Download
Abstract:
Hodgkin lymphoma, pembrolizumab, PD-1
Feedback